Bio Balance Inc is categorized under Commercial Medical Research in New York City, NY and active since 1993.
Bio Balance Inc was established in 1993, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Richard Lanzara Phd at the company’s single location by writing to 30 West 86th St, New York City, New York NY 10024 or by phoning (212) 769-3877. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Bio Balance Inc |
| Contact Person: | Richard Lanzara Phd |
| Address: | 30 West 86th St, New York City, New York 10024 |
| Phone Number: | (212) 769-3877 |
| Website Address: | bio-balance.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1993 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Bio Balance Inc was started in 1993 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Richard Lanzara Phd for inquiries that concern Bio Balance Inc by calling the company number (212) 769-3877, as your correspondence is most welcome. Additionally, the physical location of the single location of Bio Balance Inc can be found at the coordinates 40.785867,-73.971084 as well as the street address 30 West 86th St in New York City, New York 10024.
For its online presence, you may visit Bio Balance Inc’s website at bio-balance.com and engage with its social media outlets through on Twitter and on Facebook.